124 related articles for article (PubMed ID: 1466788)
21. Selective modulation of calcium-dependent myosin phosphorylation by novel protein kinase inhibitors, isoquinolinesulfonamide derivatives.
Hagiwara M; Inagaki M; Watanabe M; Ito M; Onoda K; Tanaka T; Hidaka H
Mol Pharmacol; 1987 Jul; 32(1):7-12. PubMed ID: 2955213
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of cyclic AMP-dependent protein kinase by curcumin.
Hasmeda M; Polya GM
Phytochemistry; 1996 Jun; 42(3):599-605. PubMed ID: 8768315
[TBL] [Abstract][Full Text] [Related]
23. MS-282a and MS-282b, new inhibitors of calmodulin-activated myosin light chain kinase from Streptomyces tauricus ATCC 27470.
Nakanishi S; Kita K; Uosaki Y; Yoshida M; Saitoh Y; Mihara A; Kawamoto I; Matsuda Y
J Antibiot (Tokyo); 1994 Aug; 47(8):855-61. PubMed ID: 7928670
[TBL] [Abstract][Full Text] [Related]
24. Kaempferol inhibits myosin light chain kinase.
Rogers JC; Williams DL
Biochem Biophys Res Commun; 1989 Oct; 164(1):419-25. PubMed ID: 2803309
[TBL] [Abstract][Full Text] [Related]
25. Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C.
Hidaka H; Inagaki M; Kawamoto S; Sasaki Y
Biochemistry; 1984 Oct; 23(21):5036-41. PubMed ID: 6238627
[TBL] [Abstract][Full Text] [Related]
26. Myosin light chain kinase autoregulatory pseudosubstrate prototope.
Pearson RB; Hunt JT; Mitchelhill KI; Kemp BE
Pept Res; 1991; 4(3):147-53, 156-7. PubMed ID: 1823185
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of eukaryote signal-regulated protein kinases by plant-derived catechin-related compounds.
Polya GM; Foo LY
Phytochemistry; 1994 Apr; 35(6):1399-405. PubMed ID: 7515625
[TBL] [Abstract][Full Text] [Related]
28. The mechanism of inhibition of light-chain phosphorylation by purealin in chicken gizzard myosin.
Takito J; Ohizumi Y; Nakamura H; Kobayashi J; Ebisawa K; Nonomura Y
Eur J Pharmacol; 1987 Oct; 142(2):189-95. PubMed ID: 2961581
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of calmodulin-activated smooth-muscle myosin light-chain kinase by calmodulin-binding peptides and fluorescent (phosphodiesterase-activating) calmodulin derivatives.
Török K; Cowley DJ; Brandmeier BD; Howell S; Aitken A; Trentham DR
Biochemistry; 1998 Apr; 37(17):6188-98. PubMed ID: 9558358
[TBL] [Abstract][Full Text] [Related]
30. Protein kinase inhibitors and blood pressure control in spontaneously hypertensive rats.
Buchholz RA; Dundore RL; Cumiskey WR; Harris AL; Silver PJ
Hypertension; 1991 Jan; 17(1):91-100. PubMed ID: 1986986
[TBL] [Abstract][Full Text] [Related]
31. Association of calmodulin with peptide analogues of the inhibitory region of the heat-stable protein inhibitor of adenosine cyclic 3',5'-phosphate dependent protein kinase.
Malencik DA; Scott JD; Fischer EH; Krebs EG; Anderson SR
Biochemistry; 1986 Jun; 25(12):3502-08. PubMed ID: 3755057
[TBL] [Abstract][Full Text] [Related]
32. MS-347a, a new inhibitor of myosin light chain kinase from Aspergillus sp. KY52178.
Nakanishi S; Ando K; Kawamoto I; Matsuda Y
J Antibiot (Tokyo); 1993 Dec; 46(12):1775-81. PubMed ID: 8294233
[TBL] [Abstract][Full Text] [Related]
33. Mode of inhibition of smooth muscle myosin light chain kinase by synthetic peptide analogs of the regulatory site.
Ikebe M
Biochem Biophys Res Commun; 1990 Apr; 168(2):714-20. PubMed ID: 2334433
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of turkey gizzard myosin light chain kinase activity by BAY K 8644.
Movsesian MA; Adelstein RS
Eur J Pharmacol; 1984 Aug; 103(1-2):161-3. PubMed ID: 6207034
[TBL] [Abstract][Full Text] [Related]
35. Calmodulin antagonists inhibit activity of myosin light-chain kinase independent of calmodulin.
Zimmer M; Hofmann F
Eur J Biochem; 1984 Jul; 142(2):393-7. PubMed ID: 6547673
[TBL] [Abstract][Full Text] [Related]
36. Phospholipid-sensitive Ca2+-dependent protein kinase inhibition by R-24571, a calmodulin antagonist.
Mazzei GJ; Schatzman RC; Turner RS; Vogler WR; Kuo JF
Biochem Pharmacol; 1984 Jan; 33(1):125-30. PubMed ID: 6584106
[TBL] [Abstract][Full Text] [Related]
37. Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2.
Cozza G; Mazzorana M; Papinutto E; Bain J; Elliott M; di Maira G; Gianoncelli A; Pagano MA; Sarno S; Ruzzene M; Battistutta R; Meggio F; Moro S; Zagotto G; Pinna LA
Biochem J; 2009 Jul; 421(3):387-95. PubMed ID: 19432557
[TBL] [Abstract][Full Text] [Related]
38. Effects of calyculin A on tension and myosin phosphorylation in skinned smooth muscle of the rabbit mesenteric artery.
Suzuki A; Itoh T
Br J Pharmacol; 1993 Jul; 109(3):703-12. PubMed ID: 8395295
[TBL] [Abstract][Full Text] [Related]
39. Attenuation of contractility in rat epididymal vas deferens by Rho kinase inhibitors.
Amobi NI; Chung IP; Smith IC
Auton Autacoid Pharmacol; 2006 Apr; 26(2):169-81. PubMed ID: 16553645
[TBL] [Abstract][Full Text] [Related]
40. Design of peptidase-resistant peptide inhibitors of myosin light chain kinase.
Khapchaev AY; Kazakova OA; Samsonov MV; Sidorova MV; Bushuev VN; Vilitkevich EL; Az'muko AA; Molokoedov AS; Bespalova ZD; Shirinsky VP
J Pept Sci; 2016 Nov; 22(11-12):673-681. PubMed ID: 27699916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
